4//SEC Filing
Novara Mark David 4
Accession 0001438133-25-000134
CIK 0001438133other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 5:26 PM ET
Size
9.2 KB
Accession
0001438133-25-000134
Insider Transaction Report
Form 4
Novara Mark David
EVP & CHIEF COMMERCIAL OFFICER
Transactions
- Award
Performance Stock Unit
2025-05-30+31,486→ 31,486 total→ Common Stock (31,486 underlying) - Award
Restricted Stock Unit
2025-05-30+31,488→ 31,488 total→ Common Stock (31,488 underlying)
Holdings
- 25,195
Common Stock
Footnotes (4)
- [F1]Awarded on May 30, 2025 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
- [F2]Each performance stock unit (PSU) represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the Company) common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2027 (the Measurement Date). The number of shares issued may range from 0% to 200% of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSUs will vest.
- [F3]Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
- [F4]RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2026, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
Documents
Issuer
TANDEM DIABETES CARE INC
CIK 0001438133
Entity typeother
Related Parties
1- filerCIK 0002000342
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 5:26 PM ET
- Size
- 9.2 KB